Curium Pharma nelle notizie
Leader nella medicina nucleare
Tamtam ha trovato 20 articoli recenti su Curium Pharma.
- Curium Reportedly Nears Acquisition Of Lantheus For Approximately $7 Billion
- Curium reportedly closing in on deal to buy radiopharma rival Lantheus for $7B
- Curium strikes up to $8B deal for radiopharma rival Lantheus
- Curium Announces Definitive Agreement to Merge with Lantheus
- Curium strikes $8bn deal to buy radiopharma rival Lantheus
- Curium strikes up to $8 billion deal for radiopharma peer Lantheus
- Curium Announces a Strategic Investment of Over €32 million in Saclay, France
- CVC réitère son engagement dans Curium
- Lantheus weighs potential sale with $7B valuation
- Radiopharmaceutical outfit Lantheus mulls potential $7B takeover by Curium: Bloomberg
- Curium Pharma UK Ltd
- Lantheus weighs potential $7 billion sale after Curium's offer, Bloomberg News reports
- Lantheus weighs potential $7 billion sale after Curium's offer, Bloomberg News reports
- Lantheus Explores Potential $7 Billion Sale Following Offer From Curium
- Sabine Brookman-May: Starting a New Chapter as VP Global Head of Clinical Development at Curium Pharma
- La dirstrat d’une biotech au cœur d’une transaction record dans la médecine nucléaire
- Curium Pharma Comes to Pembroke’s 2 Seaport Lane for Global HQ
- CapVest sells Curium Pharma to continuation fund at $7B valuation
- Valorisée à 7 milliards, la biotech Curium du Belge Renaud Dehareng signe une transaction record en médecine nucléaire
- « On va trouver des solutions pour 80 % des cancers » : ce patron belge est convaincu que sa technologie changera la donne d’ici à quinze ans
Articoli raccolti da Tamtam e conservati quando riguardano l'azienda, dal più recente. Ognuno rimanda alla sua fonte.
Vendi ad aziende come Curium Pharma?
Tamtam trova le aziende in linea con il tuo cliente ideale, analizza ogni account e ti dice chi contattare e quando.
Trova aziende simili